Biopharma Companies Must Break the DMTA Linearity, Says Zifo

Summary

Zifo released a position paper advocating for Design-Make-Test-Analyse workflows in biopharma to evolve from linear processes into interconnected networks that capture scientific knowledge and maintain context across samples and decisions.